A preliminary clinical validation through an immunohistochemical analysis of CRC patient tissue samples revealed a significant correlation between the expression of SDF-1 or CXCR4 and an unfavorable prognosis—particularly liver metastasis (Figure 6). Here, CXCL12 is linked to colorectal carcinoma.